Genefirst Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.85M
- Investors
-
4
Genefirst General Information
Description
Developer of a biotechnology research platform designed to develop molecular diagnostics kits and devices to aid the diagnosis of diseases. The company's devices are sensitive and affordable molecular diagnostics technologies and products that can be used in the fields of infectious disease, cancer diagnostics, and personalized medicine for the simultaneous detection of multiple targets in one reaction, enabling researchers, clinicians and drug firms to get accurate diagnoses with the delivery of more safe and effective medicines.
Contact Information
Website
www.genefirst.comCorporate Office
- Unit 2 The Quadrant, Abingdon Science Park
- Oxfordshire
- Abingdon OX14 3YS
- England, United Kingdom
Corporate Office
- Unit 2 The Quadrant, Abingdon Science Park
- Oxfordshire
- Abingdon OX14 3YS
- England, United Kingdom
Genefirst Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Grant | 01-Aug-2020 | $1.85M | Completed | Generating Revenue | ||
| 9. Later Stage VC (Series A) | 19-Mar-2020 | Completed | Generating Revenue | |||
| 8. Grant | 01-Oct-2018 | Completed | Generating Revenue | |||
| 7. Grant | 01-Mar-2018 | Completed | Generating Revenue | |||
| 6. Grant | 01-Feb-2018 | Completed | Generating Revenue | |||
| 5. Grant | 26-Oct-2017 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2017 | Completed | Generating Revenue | |||
| 3. Seed Round | 07-Jan-2015 | Completed | Generating Revenue | |||
| 2. Grant | 01-Aug-2014 | $42.6K | Completed | Generating Revenue | ||
| 1. Corporate | 01-Jan-2014 | Completed | Generating Revenue |
Genefirst Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | ||||||||
| Series A Preferred | ||||||||
| Series A Preferred | 587,500 | $0.000127 | $4.56 | $4.56 | 1x | $4.56 | 28.2% | |
| Ordinary | 49,380 | $0.000127 | $3.1 | $3.1 | 1x | $3.1 | 2.37% |
Genefirst Comparisons
Industry
Financing
Details
Genefirst Competitors (16)
One of Genefirst’s 16 competitors is ROCA Test, a Formerly VC-backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ROCA Test | Formerly VC-backed | Cambridge, United Kingdom | ||||
| Resolution Bioscience | Formerly Angel backed | Redmond, WA | ||||
| OncoCyte | Formerly VC-backed | Irvine, CA | ||||
| Vortex Biosciences | Venture Capital-Backed | Pleasanton, CA | ||||
| Predicine | Venture Capital-Backed | Hayward, CA |
Genefirst Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Genefirst Patents
Genefirst Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202319458-D0 | High throughput library normalisation | Pending | 19-Dec-2023 | ||
| GB-202317897-D0 | Methods, compositions, and kits for detecting severe hpv infection | Pending | 23-Nov-2023 | ||
| GB-202308392-D0 | Methods, compositions, and kits for preparing library and targeted sequencing | Inactive | 06-Jun-2023 | ||
| GB-202108427-D0 | Methods, compositions, and kits for preparing sequencing library | Inactive | 14-Jun-2021 | ||
| AU-2022294211-A1 | Methods, compositions, and kits for preparing sequencing library | Pending | 14-Jun-2021 | C12N15/1068 |
Genefirst Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Genefirst Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institute for Health Research | Government | |||
| Horizon 2020 SME Instrument | Government | Minority | ||
| Innovate UK | Accelerator/Incubator | |||
| Fosun Pharma | Corporation | Minority |
Genefirst FAQs
-
When was Genefirst founded?
Genefirst was founded in 2011.
-
Where is Genefirst headquartered?
Genefirst is headquartered in Abingdon, United Kingdom.
-
What is the size of Genefirst?
Genefirst has 13 total employees.
-
What industry is Genefirst in?
Genefirst’s primary industry is Diagnostic Equipment.
-
Is Genefirst a private or public company?
Genefirst is a Private company.
-
What is Genefirst’s current revenue?
The current revenue for Genefirst is .
-
How much funding has Genefirst raised over time?
Genefirst has raised $6.2M.
-
Who are Genefirst’s investors?
National Institute for Health Research, Horizon 2020 SME Instrument, Innovate UK, and Fosun Pharma have invested in Genefirst.
-
Who are Genefirst’s competitors?
ROCA Test, Resolution Bioscience, OncoCyte, Vortex Biosciences, and Predicine are some of the 16 competitors of Genefirst.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
